October 04, 2024 at 04:30PM Meeting 1: Patient and Care Partner Perspectives on Safety Considerations for Approved Gene Therapy Treatments for Rare Diseases - 09/20/2024
FDA CBER Patient Listening Meeting: Patient and Care Partner Perspectives on Safety Considerations for Approved Gene Therapy Treatments for Rare Diseases
via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/laVh7Wb
No comments:
Post a Comment